In the female breast cancers group, there were 25 cases of HER2 IHC 0, 28 cases of HER2 IHC 1+, 23 cases of HER2 IHC 2+, 17 cases of HER2 IHC 3+. This evidence concerns the gene ERBB2 and breast carcinoma.